Boxer Capital as of Dec. 31, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 24 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Beigene (BGNE) | 15.6 | $126M | 900k | 140.26 | |
Solid Biosciences | 11.6 | $94M | 3.5M | 26.80 | |
Ptc Therapeutics I (PTCT) | 9.1 | $74M | 2.2M | 34.32 | |
Wave Life Sciences (WVE) | 8.6 | $69M | 1.7M | 42.04 | |
Mirati Therapeutics | 8.2 | $66M | 1.6M | 42.42 | |
Intercept Pharmaceuticals In | 7.5 | $61M | 600k | 100.79 | |
Esperion Therapeutics (ESPR) | 6.8 | $55M | 1.2M | 46.00 | |
Odonate Therapeutics Ord | 5.2 | $42M | 3.0M | 14.08 | |
Uniqure Nv (QURE) | 4.3 | $35M | 1.2M | 28.82 | |
Rocket Pharmaceuticals (RCKT) | 3.6 | $29M | 2.0M | 14.82 | |
Dbv Technologies S A (DBVT) | 3.6 | $29M | 4.5M | 6.42 | |
Global Blood Therapeutics In | 3.5 | $29M | 700k | 41.05 | |
Amarin Corporation (AMRN) | 2.5 | $20M | 1.5M | 13.61 | |
Cymabay Therapeutics | 2.0 | $17M | 2.1M | 7.87 | |
Immunomedics | 2.0 | $16M | 1.2M | 14.27 | |
Kura Oncology (KURA) | 1.5 | $12M | 845k | 14.04 | |
Kiniksa Pharmaceuticals (KNSA) | 1.0 | $8.2M | 291k | 28.09 | |
Mei Pharma | 0.9 | $7.7M | 2.9M | 2.64 | |
Esperion Therapeutics Inc Ne | 0.6 | $4.6M | 100k | 46.00 | |
Medicines Company | 0.6 | $4.4M | 232k | 19.14 | |
Kalvista Pharmaceuticals (KALV) | 0.5 | $4.0M | 200k | 19.75 | |
Matinas Biopharma Holdings, In (MTNB) | 0.4 | $3.4M | 5.6M | 0.60 | |
Reata Pharmaceuticals Inc Cl A | 0.3 | $2.8M | 50k | 56.10 | |
Novus Therapeutics | 0.1 | $519k | 324k | 1.60 |